Business Description
Glycorex Transplantation AB
ISIN : SE0000524530
Share Class Description:
NGM:GTAB B: Class BCompare
Compare
Traded in other countries / regions
GTAB B.Sweden IPO Date
1999-12-28Description
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -1.32 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.73 | |||||
| Beneish M-Score | -4.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.4 | |||||
| 3-Year EPS without NRI Growth Rate | -55 | |||||
| 3-Year FCF Growth Rate | -160.1 | |||||
| 3-Year Book Growth Rate | -22.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.65 | |||||
| 9-Day RSI | 39.86 | |||||
| 14-Day RSI | 43.86 | |||||
| 6-1 Month Momentum % | -46.67 | |||||
| 12-1 Month Momentum % | -73.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.36 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 706.56 | |||||
| Days Sales Outstanding | 70.85 | |||||
| Days Payable | 265.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.66 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.63 | |||||
| Operating Margin % | -101.27 | |||||
| Net Margin % | -101.34 | |||||
| FCF Margin % | -43.44 | |||||
| ROE % | -48.17 | |||||
| ROA % | -35.16 | |||||
| ROIC % | -46.42 | |||||
| ROC (Joel Greenblatt) % | -164.19 | |||||
| ROCE % | -42.42 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.11 | |||||
| PB Ratio | 1.43 | |||||
| Price-to-Tangible-Book | 2.95 | |||||
| EV-to-EBIT | -2.02 | |||||
| EV-to-EBITDA | -6.96 | |||||
| EV-to-Revenue | 2.02 | |||||
| EV-to-FCF | -4.87 | |||||
| Price-to-Projected-FCF | 3.06 | |||||
| Price-to-Median-PS-Value | 0.35 | |||||
| Price-to-Net-Current-Asset-Value | 14.27 | |||||
| Earnings Yield (Greenblatt) % | -49.35 | |||||
| FCF Yield % | -20.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Glycorex Transplantation AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 29.962 | ||
| EPS (TTM) (kr) | -0.405 | ||
| Beta | 0.49 | ||
| Volatility % | 61.78 | ||
| 14-Day RSI | 43.86 | ||
| 14-Day ATR (kr) | 0.118535 | ||
| 20-Day SMA (kr) | 0.95805 | ||
| 12-1 Month Momentum % | -73.56 | ||
| 52-Week Range (kr) | 0.75 - 3.54 | ||
| Shares Outstanding (Mil) | 73.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Glycorex Transplantation AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Glycorex Transplantation AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Glycorex Transplantation AB Frequently Asked Questions
What is Glycorex Transplantation AB(NGM:GTAB B)'s stock price today?
The current price of NGM:GTAB B is kr0.86. The 52 week high of NGM:GTAB B is kr3.54 and 52 week low is kr0.75.
When is next earnings date of Glycorex Transplantation AB(NGM:GTAB B)?
The next earnings date of Glycorex Transplantation AB(NGM:GTAB B) is 2024-05-23.
Does Glycorex Transplantation AB(NGM:GTAB B) pay dividends? If so, how much?
Glycorex Transplantation AB(NGM:GTAB B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers